Amsterdam (ots/PRNewswire) - Panel to contribute to Pharma Insights reports and second addition of the
CPhI annual report due to be launched at CPhI Worldwide 2014
Panel members for 2014:
- Prabir Basu, President at Pharma Manufacturing
- Girish Malhotra, President & Founder, Epcot International
- Hedley Rees, Managing Director at PharmaFlow Ltd
- Ajaz Hussain, CSO & President Biotechnology at Wockhardt
- Sam Venugopal, Director in the Healthcare Practice at PWC
- William Botha, Consultant and Founder Interlean
- Emil Ciurczak, President at Doramaxx Consulting
- Dilip G Shah, CEO of Vision Consulting Group and a regulatory expert
- Vijay Shah, COO at Piramal Enterprises and pharma business lead
CPhI Worldwide [http://www.cphi.com], organised by UBM Live, announces its initial line-up of confirmed expert industry panel members for 2014 - building on the huge success of the CPhI annual report launched at CPhI Worldwide in October 2013.
(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )
This year's panel sees the return of nine thought leaders, with further members joining imminently. Additionally, this year panel members will also be utilising their market insights and analysis year-round in the CPhI Pharma Insights series, which covers individual topics and developments across the industry - including the recently launched R&D and manufacturing reports.
Expertise ranges from API and manufacturing efficiencies (Girish Malhotra) to quality systems and supply chain activities (Sam Venugopal), with insights also provided from some of the sectors' biggest names and innovators, like Piramal's Vijay Shah. In addition, the panel features regulatory heavyweight Ajaz Hussain of Wockhardt - renowned for coining the term PAT - who will lend his expertise on establishing and improving drug regulation. Across supply chain issues, the panel will leverage the knowledge of Hedley Rees, whilst Prabir Basu, formerly of the National Institute for Pharmaceutical Technology and Education (NIPTE), will focus on the industry's approach to innovation.
Regulatory expert, predominantly focussed on the Indian market, Dilip Shah also returns, covering the intellectual property rules around innovation.
Emil Ciurczak, also previously a member of the FDA's PAT committee and president of Doramaxx Consulting [http://www.linkedin.com/search?search=&company=Doramaxx+Consulting&sortCriteria=R&keepFacets=true&trk=prof-exp-company-name] , draws up his expertise across PAT, QbD and spectroscopy. Finally, William Botha, a respected trainer and mentor in manufacturing, is also retuning to the panel; he is fluent in FDA regulations, including GDP and GMP.
Last year's report examined a number of major issues and developments across the industry including cost savings through QbD and PAT, to regulatory challenges from a globalised industry, right through to the effect breakthrough drugs like ADCs will have on overcoming future disease pathologies.
"Last year's report was a huge success with our experts, providing a combined insight into the overall picture of the industry. What is interesting this year is to see the progress the industry has made, and what new problems or challenges there are. In the first annual report insights spanned a mixture of practical manufacturing improvements, like single-use reactors and continuous processing, mixed with regulatory risks and the future potential of breakthrough drugs like ADCs and supply chain issues. Everything from life-saving drugs to an open assessment of where industry risks lay, and culminating in the new business model emerging- with increased partnerships, innovation sharing and consolidation. Further, our experts offered conclusions on the necessary techniques, technologies and a simplified regulatory approach that will simultaneously increase safety and innovation," commented Chris Kilbee, Group Director Pharma at CPhI.
The 2014 annual report will feature a collection of in-depth essays from each panel member - with experts given carte blanche to prophesize how the industry will look and operate in the future from both an economic and practical perspective. Additionally, the CPhI Pharma Insights reports contain a mixture of primary data (industry surveys) and expert comment on what these findings show about the general direction of the industry and any issues they feel need to be addressed.
CPhI is now in the later stages of assembling the panel's full line-up and plans to announce all participants in the summer - with a few more global heavyweights expected.
Kilbee added: "I am delighted that we have been able to source so many leading figures from within the industry to take part in the panel, as collectively they bring a huge amount of experience and insight. Already the panel's knowledge spans pharmaceutical ingredients, manufacturing processes, global supply chain issues and regulatory frameworks. One thing they all have in common is a wealth of experience across international markets and a practical approach to problem solving, which will be invaluable in postulating future market dynamics."
For more information, please contact: firstname.lastname@example.org
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, China, India, Japan, Southeast Asia, Istanbul, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.
For more information visit: http://www.cphi.com
The UBM Live annual schedule of Pharmaceutical events also includes CPhI Russia and IPhEB (16-17 April, 2014 at the Lenexpo Exhibition Complex- St Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014 at the Jakarta International Expo- Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, at the Lutfi Kirdar Convention and Exhibition Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC- Shanghai, China); CPhI South America (5-7 August 2014 at Expo Centre Norte, Sao Paulo- Brazil); CPhI, ICSE Korea (2-3 September, 2014 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide ; CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre- Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan .
About UBM Live
UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.
For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: email@example.com / firstname.lastname@example.org